About
Protein Therapeutics
Areas of Focus
Categories
Biologics & BiopharmaceuticalAntibodyBiotech
Team (11)
Clinical Trials (7)
View allTotal Trials
7
As Lead Sponsor
7
As Collaborator
0
Total Enrollment
371
By Phase
PHASE1: 6PHASE1/PHASE2: 1
By Status
RECRUITING: 5COMPLETED: 2
Clinical Trials Pipeline7 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2021
2022
2023
2024
2025
2026
2027
2028
Today
Hover over trial bars to see details
Recent Trials
NCT06999187Lead Sponsor
A Study of DR-0202 in Patients With Locally Advanced or Metastatic, Relapsed or Refractory Carcinomas
PHASE1Recruiting
96 participants
Started: Jun 3, 2025 · Completed: Dec 31, 2027
NCT06647069Lead Sponsor
DR-0201 in Subjects With Autoimmune Diseases
PHASE1Recruiting
36 participants
Started: Mar 27, 2025 · Completed: Dec 31, 2026
NCT06766864Lead Sponsor
A Study of Subcutaneous DR-01 in Healthy Volunteers
PHASE1Completed
32 participants
Started: Mar 3, 2025 · Completed: Aug 27, 2025
NCT06602232Lead Sponsor
A Study of DR-01 in Subjects With Alopecia Areata and Vitiligo
PHASE1Recruiting
80 participants
Started: Oct 30, 2024 · Completed: Sep 30, 2026
NCT06392477Lead Sponsor
A Study of DR-0201 in Subjects With Relapsed/Refractory B-Cell Non-Hodgkin Lymphoma
PHASE1Recruiting
48 participants
Started: Jul 8, 2024 · Completed: Dec 31, 2026
Locations (1)
Headquarters
Foster City, CA, United States
Map
Loading map...